Microdosing a compounded GLP-1 drug "can be risky," according to the FDA
Further evidence from a case report of bilateral NAION following weight loss on semaglutide illustrates how nonarteritic anterior ischemic optic neuropathy appears in real-world use
Tenders for innovative drugs, often subject to growing and hard-to-predict demand within the rigid timelines of healthcare bureaucracy, regularly encounter difficulties
For a woman who maintains at 2,200, the target is 2,650 to 2,700
Polycystic Ovary Syndrome Polycystic ovary syndrome may provide useful clinical insights into the relationship between androgen excess, insulin signalling and metabolic dysfunction
Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population